Atibuclimab
- Generic Name
- Atibuclimab
- Drug Type
- Biotech
- CAS Number
- 2417175-94-9
- Unique Ingredient Identifier
- 23IQ3PO968
Overview
Atibuclimab (IC14) is a chimeric CD14 antibody investigated for the treatment of patients with severe sepsis.
Background
Atibuclimab (IC14) is a chimeric CD14 antibody investigated for the treatment of patients with severe sepsis.
Indication
Investigated for use/treatment in sepsis and septicemia and pneumonia.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath